Akebia Therapeutics (AKBA) PT Lowered to $18 at Needham & Company

August 9, 2018 1:40 PM

Needham & Company lowered its price target on Akebia Therapeutics (NASDAQ: AKBA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found